A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors
A Pilot Study of Oral Minoxidil for the Treatment of Persistent Hair Loss in Pediatric, Adolescent, and Young Adult Cancer Survivors
In the register
The register attaches this trial to Minoxidil (low-dose oral), currently at “Marketed, off-label” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Active, not recruiting
- Declared phase
- Phase 2
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Participants (registry)
- 10
- Start
- March 2023
- Primary completion
- March 2027 (planned)
- Study completion
- March 2027 (planned)
- Last registry update
- February 2026
- Countries
- United States
Conditions studied: Survivors of Childhood Cancer, Alopecia
Interventions: Oral Minoxidil, Placebo
Other trials of Minoxidil (low-dose oral)
- NCT07018349Not yet recruiting
Low Dose Oral Minoxdil in Androgenic Alopecia
Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.